Search & Analyze

Sudeep Pharma Ltd.

1,066.70−64.25 (−5.68%)

BSE · 30 Oct, 4:01 PM

: ₹12,048.23 Cr
: 63.97
: 20,129
: ₹1,139.80 - ₹1,061.00
: ₹1,376.00 - ₹524.95

Sudeep Pharma Ltd. (SUDEEPPHRM) share price closed at ₹1,066.70 on the BSE on Friday, October 30, 2026, down by 5.68% from its of ₹1,130.95. In that session SUDEEPPHRM reached a of 1,139.80 and of 1,061.00. The for the session was 1,085.52. The stands at 1,135.80 and is at 822.55. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹1,126.05

₹1,130.95

₹1,085.52

₹1,135.80

Price 6.08% below

₹822.55

Price 29.68% above

Key Fundamentals

: 12,048.23 Cr₹12.05 Thousand Crore
: 16.67
: 63.97
: 12.59
: 84.76
: 275.41 Cr₹275.41 Crore
: 0.14 %
Sector
Industry: Pharmaceuticals & Drugs
: 25.37
: 0.17

Industry Comparison

Ratio	Company	Sector
	63.97	44.77
	0.17	0.20
	12.59	4.61
	3.09	1.81
	0.14 %	0.11 %
Operating Margin	34.05 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Sudeep Pharma Ltd. SUDEEPPHRM	1,066.70	63.97	12,048.23	0.14	51.81	10.76%	196.70	20.92%	28.50

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	148.80	115.54	157.55	124.92	162.67	172.34	182.34	158.27	196.70
Expenses	85.33	76.24	98.77	81.04	107.21	112.37	119.74	103.36	123.46
	63.47	39.30	58.78	43.88	55.46	59.97	62.60	54.91	73.24
	42.66%	34.01%	37.31%	35.12%	34.10%	34.80%	34.33%	34.69%	37.23%
	1.87	2.44	3.76	5.16	10.17	6.84	6.43	5.45	5.98
Interest	1.05	1.41	1.85	1.71	2.28	1.17	2.44	2.06	2.81
	2.58	2.67	2.83	3.25	3.81	3.86	3.88	4.00	5.38
	61.72	37.66	57.85	44.07	59.53	61.78	62.69	54.29	71.03
	21.01%	23.75%	23.62%	29.05%	21.43%	22.79%	22.58%	25.24%	27.06%
	48.75	28.71	44.19	30.81	45.75	47.46	48.88	40.55	51.45
	12.81	2.95	4.54	3.17	4.71	4.20	4.33	3.59	4.56

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	343.01	428.74	459.28	523.80	654.32
	343.01	428.74	459.28	502.00	642.26
EXPENDITURE :
Increase/Decrease in Stock	-10.48	-17.68	11.57	-43.84	-42.20
Raw Material Consumed	138.30	191.86	149.96	195.90	263.98
Power & Fuel Cost	9.67	1.20	9.63	10.36	12.13
Employee Cost	15.55	66.10	29.41	38.34	51.89
Other Manufacturing Expenses	10.04	27.19	23.22	33.44	31.05
General and Administration Expenses	65.41	17.48	26.38	35.88	43.11
Selling and Distribution Expenses	41.52	35.15	23.87	36.21	48.28
Miscellaneous Expenses	5.53	17.28	2.78	4.69	11.21
	275.55	338.58	276.81	310.99	419.46
Operating Profit (Excl OI)	67.46	90.16	182.47	191.01	222.80
	7.39	9.52	6.10	9.33	28.59
	74.85	99.68	188.57	200.34	251.39
Interest	1.72	5.78	4.74	6.90	8.50
PBDT	73.13	93.90	183.83	193.44	242.88
	4.53	7.92	9.01	10.59	14.81
Profit Before Taxation & Exceptional Items	68.60	85.98	174.82	182.85	228.07
	68.60	85.98	174.82	182.85	228.07
Provision for Tax	18.44	23.66	41.63	44.12	53.79
	50.17	62.32	133.19	138.73	174.28
Extra items				0.00	0.00
Minority Interest					-1.39
Consolidated Net Profit	50.17	62.32	133.19	138.73	172.89
Profit Balance B/F	100.92	150.55	212.93	345.70	483.45
Appropriations	151.09	212.88	346.11	484.43	656.34
Equity Dividend %					150.00%
	356.01	442.31	945.26	14.27	15.31
Adjusted EPS	5.17	6.42	13.72	14.27	15.31

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	1.41	1.41	1.41	11.98	11.29
Total Reserves	161.93	221.88	354.63	481.12	872.04
Reserve excluding Revaluation Reserve	161.93	221.88	354.63	481.12	872.04
Revaluation reserve	0.00	0.00	0.00
	163.34	223.29	356.03	493.09	883.34
Minority Interest					14.75
Secured Loans	28.23	19.94	11.14	39.55	34.29
Deferred Tax Assets / Liabilities	4.44	4.59	5.62	6.03	8.91
Other Long Term Liabilities		0.54	2.30	1.66	31.10
Long Term Provisions	0.81	0.38	1.32	1.75	0.04
Total Non-Current Liabilities	33.48	25.46	20.38	49.00	74.33
Trade Payables	26.70	38.50	50.71	60.48	68.43
Other Current Liabilities	1.47	70.85	25.19	24.91	29.27
Short Term Borrowings	55.46	51.82	54.08	85.68	102.06
Short Term Provisions	63.35	9.67	7.24	3.68	2.20
Total Current Liabilities	146.98	170.83	137.22	174.76	201.96
Total Liabilities	343.80	419.57	513.64	716.85	1,174.38
Gross Block	156.86	166.13	197.15	215.94	378.42
Less: Accumulated Depreciation	20.15	7.91	16.92	26.61	41.49
	136.71	158.23	180.23	189.33	336.94
	8.13	25.97	44.66	88.22	178.43
Long Term Investment	0.00	0.00	0.00
Long Term Loans & Advances	2.36	5.08	13.06	14.84	13.14
Other Non Current Assets	0.00	0.27	0.32	0.33	15.35
Total Non-Current Assets	147.20	189.55	238.27	292.73	550.42
Currents Investments		3.03	0.13	0.14
Inventories	36.54	71.00	66.58	128.67	216.05
Sundry Debtors	106.92	93.71	144.57	185.35	227.54
Cash and Bank	21.47	10.30	13.98	51.81	114.65
Other Current Assets	0.50	3.88	5.71	19.07	9.54
Short Term Loans and Advances	31.18	48.09	44.40	39.08	56.19
Total Current Assets	196.61	230.02	275.36	424.12	623.97
Net Current Assets (Including Current Investments)	49.63	59.19	138.14	249.36	422.00
Total Assets	343.80	419.57	513.64	716.85	1,174.38
	0.26	0.10	0.10	0.10
Total Debt	83.69	82.20	74.90	135.25	148.29
	1,159.15	1,584.71	2,526.86	50.48	78.21
Adjusted Book Value	16.82	23.00	36.67	50.48	78.21

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	68.60	85.98	174.82	182.85	228.07
Adjustment	5.01	17.91	13.46	15.45	9.02
Changes In working Capital	-59.02	-33.07	-77.85	-109.02	-112.07
Cash Flow after changes in Working Capital	14.59	70.82	110.43	89.28	125.03
Cash Flow from Operating Activities	-2.98	48.40	65.69	48.73	69.55
Cash Flow from Investing Activities	-38.42	-50.02	-49.28	-78.76	-330.93
Cash Flow from Financing Activitie	50.92	-9.78	-12.74	52.70	247.29
Net Cash Inflow / Outflow	9.52	-11.40	3.67	22.67	-14.09
Opening Cash & Cash Equivalents	11.96	21.47	10.30	13.98	36.81
Cash & Cash Equivalent on Amalgamation / Take over / Merger					3.74
Effect of Foreign Exchange Fluctuations		0.23	0.01	0.16	0.28
Closing Cash & Cash Equivalent	21.47	10.30	13.98	36.81	26.74

Ratios

Valuation

63.97

12.59

44.01

16.98

16.67

84.76

Profitability

25.37

28.50

18.43

34.05

26.64

Leverage & Liquidity

0.17

3.09

27.82

Returns

0.14

0.69

Shareholding Pattern

Numbers in percentages

Particulars	Mar '24	Nov '25	Dec '25	Mar '26	Jun '26	Sep '26
	44.65	76.15	76.15	76.15	76.15	76.15
		15.64	19.27	19.66	17.46	16.98
	55.35	8.20	4.58	4.18	6.39	6.87
	55.35	23.85	23.85	23.85	23.85	23.85
No. of Shareholders	5	2,17,982	43,599	36,503	35,695	40,465

Mutual Funds Invested(35)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 28 active funds hold 7.36% in Sudeep Pharma Ltd., contributing to ₹1.00K Cr of holdings

Fund				As of
AX Axis Small Cap Fund - Growth - Direct PlanSmall cap Fund	241.41	0.79	20,02,038	Sep '26
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	163.99	2.79	13,60,000	Sep '26
HD HDFC Manufacturing Fund - Growth - Direct PlanEquity - Thematic Fund - Other	100.08	0.97	8,30,000	Sep '26
SB SBI MNC Fund - Growth - Direct PlanMNC	82.90	1.30	6,87,500	Sep '26
SB SBI Comma Fund - Growth - Direct PlanEquity - Thematic Fund - Other	82.83	6.86	6,86,955	Sep '26
ED Edelweiss Recently Listed IPO Fund - Growth - Direct PlanEquity - Thematic Fund - Other	46.26	3.63	3,83,673	Sep '26
AB Aditya Birla Sun Life Small Cap Fund - Growth - Direct PlanSmall cap Fund	43.38	0.71	3,59,797	Sep '26
SB SBI Retirement Benefit Fund - Aggressive Plan - Growth - Direct PlanEquity Oriented	39.49	1.29	3,27,521	Sep '26
TR TRUSTMF Small Cap Fund - Growth - Direct PlanSmall cap Fund	37.86	0.98	3,14,018	Sep '26
PI PGIM India Small Cap Fund - Growth - Direct PlanSmall cap Fund	28.94	1.66	2,40,000	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-21	Board Meeting	Quarterly Results
2026-07-27	Board Meeting	Quarterly Results
2026-07-10	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Sudeep Pharma Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Dimple Mehta

Company Secretary & Compliance Officer

—

Sujit Jaysukh Bhayani

Managing Director

₹3.50 Cr

Mar '26

Shanil Sujit Bhayani

Whole Time Director

₹1.75 Cr

Mar '26

Ajay Shrirang Kandelkar

Whole Time Director

₹92.53 L

Mar '26

Milin Mehta

Non Independent & Non Executive Director

—

Samaresh Parida

Non Executive Independent Director

₹11.75 L

Mar '26

Raghunandan Sathyanarayan Rao

Non Executive Independent Director

₹9.50 L

Mar '26

Reshma Patel

Non Executive Independent Director

₹11.25 L

Mar '26

Sujit Gulati

Non Executive Independent Director

₹10.00 L

Mar '26

SUDEEPPHRM Latest News

News

8 of 8 articles

EQUITY29 Oct 2026 · 13:05

Sudeep Pharma informs about newspapers publication

COMPANY26 Oct 2026 · 16:12

Sudeep Pharma gets Gujarat FDA's nod to commence operations at new pharma plant in Gujarat

Commercial supplies from this facility are expected to commence in H2 FY27, following the completion of customer qualification processes

EQUITY26 Oct 2026 · 15:01

Sudeep Pharma informs about press release

EQUITY23 Sept 2026 · 17:35

Sudeep Pharma informs about investor conference

EQUITY16 Sept 2026 · 14:58

Sudeep Pharma informs about analyst meet

EQUITY5 Aug 2026 · 12:02

Sudeep Pharma submits newspaper publication

EQUITY25 Jun 2026 · 17:06

Sudeep Pharma informs about closure of trading window

EQUITY21 May 2026 · 16:19

Sudeep Pharma reports Profit after tax of Rs 257.64 Mln, in the March 2026 quarter

Sudeep Pharma Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(35)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

SUDEEPPHRM Latest News

News